[
  {
    "doc_id": "PMID_41593683",
    "summary": "Evidence for the net benefit of aspirin for primary prevention of cardiovascular disease (CVD) is finely balanced, leading to variation in guideline recommendations internationally. [95%CI 0.24-0.36] to 11.42 [95%CI 0.24-0.36] to 11.42"
  },
  {
    "doc_id": "PMID_41543478",
    "summary": "Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as effective weight loss agents, with growing evidence suggesting potential benefits in MASH. The pooled serious adverse event rate for GLP-1RAs was comparable to placebo."
  },
  {
    "doc_id": "PMID_41629827",
    "summary": "Modifiable lifestyle factors, particularly diet, may play a key role in renal health. These findings highlight the potential for dietary interventions that promote overall healthy eating patterns to contribute to the primary prevention of CKD. These findings highlight the potential for dietary interventions that promote overall healthy eating patterns to contribute to the primary prevention of CKD."
  },
  {
    "doc_id": "PMID_41551204",
    "summary": "We aim to evaluate the effectiveness of the novel real-time continuous glucose monitoring (rtCGM) system \" This prospective, open-label, randomized controlled trial included 172 patients with T2D from the Fatebenefratelli-Sacco Hospital in Milan."
  },
  {
    "doc_id": "PMID_41592063",
    "summary": "Moderate-to-strong correlations were observed, strongest at Week 4 (Rho = 0.65, 95% CI, 0.52-0.75, P < .001). Moderate-to-strong correlations were observed, strongest at Week 4 (Rho = 0.65, 95% CI, 0.52-0.75, P < .001)."
  },
  {
    "doc_id": "PMID_41540107",
    "summary": "PCI was superior in 29.2% of comparisons, medical therapy in 23.3%, and the two groups were tied in 47.5%, resulting in a win ratio of 1.25 in favor of PCI (95% confidence interval (CI) 1.01-1.56, P = 0.043). PCI was superior in 29.2% of comparisons, medical therapy in 23.3%, and the two groups were tied in 47.5%, resulting in a win ratio of 1.25 in favor of PCI (95% confidence interval (CI) 1.01-1.56, P = 0.043). ClinicalTrials.gov"
  },
  {
    "doc_id": "PMID_41629143",
    "summary": "SGLT2 inhibitorsTheir Evidence suggests that SGLT2i may reduce chronic diuretic requirements, improve renal function, and provide additional cardiovascular protection."
  },
  {
    "doc_id": "PMID_41654775",
    "summary": "This study aimed to evaluate the risk of doxorubicin-induced cardiotoxicity in newly diagnosed breast cancer patients with type 2 diabetes receiving dapagliflozin in addition to metformin, using echocardiographic methods, and to investigate the potential cardioprotective effects of dapagliflozin. The favorable changes observed in LVEF, LVGLS, and NT-proBNP parameters suggest that dapagliflozin may be considered a potential cardioprotective agent and incorporated into preventive strategies against chemotherapy-related cardiotoxicity in diabetic patients. The favorable changes observed in LVEF, LVGLS, and NT-proBNP parameters suggest that dapagliflozin may be considered a potential cardioprotective agent and incorporated into preventive strategies against chemotherapy-related cardiotoxicity in diabetic patients."
  },
  {
    "doc_id": "PMID_41609932",
    "summary": "There were significant main effects of bupropion dosage level (low, medium, or high) (p = 0.04) and number of falls during the six months prior to study entry (p < 0.001). There were significant main effects of bupropion dosage level (low, medium, or high) (p = 0.04) and number of falls during the six months prior to study entry (p < 0.001)."
  },
  {
    "doc_id": "PMID_41553512",
    "summary": "Heart failure (HF) patients with concomitant coronary artery disease (CAD) and type 2 diabetes mellitus (DM) represent a particularly high-risk population with increased morbidity and mortality. Statin use increased from 22.3% to 82.4%, ACEi/ARB/ARNI from 58.2% to 89.3%, beta-blockers from 44.8% to 86.8%, and MRAs from 23.4% to 67.3%. Independent adverse outcome predictors were low hemoglobin, high HbA1c, impaired renal function, and reduced LVEF."
  },
  {
    "doc_id": "PMID_41572076",
    "summary": "The behavioural tests were performed after eight weeks of inducing diabetes. Real-time polymerase chain reaction was used to carry out expression analysis. These findings highlight potential therapeutic targets for mitigating diabetes-associated neurobehavioral dysfunction."
  },
  {
    "doc_id": "PMID_41623057",
    "summary": "The mean age was 67.6\u00b110.2 years, 24% were female, and 29% had diabetes. The mean age was 67.6\u00b110.2 years, 24% were female, and 29% had diabetes."
  },
  {
    "doc_id": "PMID_41574965",
    "summary": "Lorcaserin reduced total body weight (time*treatment, p = 0.004). Lorcaserin reduced total body weight (time*treatment, p = 0.004). Lorcaserin may improve cardiometabolic health primarily through reductions in central adiposity."
  },
  {
    "doc_id": "PMID_41539381",
    "summary": "Seasonal peaks are consistently associated with excess hospitalizations and mortality. Randomized trials and meta-analyses consistently support vaccination as a powerful preventive tool, associated with a 25-37% reduction in major adverse cardiovascular events and mortality, with benefits comparable to established cardioprotective therapies."
  },
  {
    "doc_id": "PMID_41625815",
    "summary": "Psychological measures improved, with PSS scores dropping from 17.7 \u00b1 3.2 to 9.80 \u00b1 1.67 in YG and 16.0 \u00b1 2.3 to 9.53 \u00b1 1.48 in CYG; smaller reductions occurred in GH and Control. Psychological measures improved, with PSS scores dropping from 17.7 \u00b1 3.2 to 9.80 \u00b1 1.67 in YG and 16.0 \u00b1 2.3 to 9.53 \u00b1 1.48 in CYG; smaller reductions occurred in GH and Control. This safe, holistic approach enhances overall quality of life, though long-term studies are needed to confirm the sustainability of these benefits and their impact on diabetes-related complications."
  },
  {
    "doc_id": "PMID_41557987",
    "summary": "Adherence was measured semiannually for 3 years using a validated three-item scale (0-100, lowest to highest adherence) in a substudy (N = 1,739). Medication adherence was consistently high in GRADE."
  },
  {
    "doc_id": "PMID_41533371",
    "summary": "Pancreas divisum is implicated as an obstructive cause for acute pancreatitis. ClinicalTrials.gov ClinicalTrials.gov"
  },
  {
    "doc_id": "PMID_41550872",
    "summary": "The optimal combination therapy for heart failure with reduced ejection fraction (HFrEF) involving sodium-glucose transporter 2 inhibitors (SGLT2i), angiotensin receptor-neprilysin inhibitors (ARNI), and conventional triple therapy remains uncertain due to the lack of direct comparative evidence. The safety profiles differ significantly, particularly regarding hypotension risk with ARNI and renal protection with SGLT2i. The safety profiles differ significantly, particularly regarding hypotension risk with ARNI and renal protection with SGLT2i."
  }
]